01 January 2003
A trial of objective comparison of quality of life between chronic renal failure patients treated with hemodialysis and renal transplantation.
Tomasz Wesołowski, Piotr SzyberAnn Transplant 2003; 8(2): 48-54 :: ID: 142803
Abstract
An interesting issue is a hemodialysis patients' and renal transplant recipients'subjective assessment of their QOL as a basic sociological criterion of treatment efficacy. The aim ofthe study is an estimation and comparison of QOL between these patients with a questionnaire the WHOQOL-100as a trial of objective comparison of quality of life between these two groups of patients. A methodof diagnostic probing with use of the questionnaire in its Polish language version was employed. A numberof 400 (in total) questionnaires (200 in each group) were given to randomly chosen CRF patients. Fulfilledquestionnaires were obtained from 144 (36%) patients who underwent the study: 61 from HD group (30.5%)and 83 from TX group (41.5%). RESULTS: Regarding sex and education, differences between groups were notsignificant statistically. As for the age and marital status, differences between groups were significant(p = 2.5 E-13 and p = 0.0045 respectively). In the both groups, (living from the health pension fromthe Government Health Insurance--ZUS) was overwhelming (HD--96.12% and TX--77.11%). A difference in amountof 'having a job' patients between groups was not significant (p = 0.153). In QOL estimation, significantdifferences between group HD and TX were assessed in overall QOL (p = 1.04 E-07), in physical domain(p = 0.00053) and social relationships domain (p = 0.0004). In the rest of domains, scores were approximatein both groups and did not differ significantly. Comparing facets scores, some significant differencesbetween HD and TX groups were observed: pain and discomfort (p = 0.032), energy and fatigue (p = 2.2E-05), positive feelings (p = 0.002), body image and appearance (p = 0.010), mobility (p = 0.031), activitiesof daily living (p = 0.036), working capacity (p = 0.008), personal relationships (p = 0.004), sexualactivity (p = 7.3 E-06) and transport (p = 0.036). Higher scores were stated in TX group in all of thosefacets excluding body image and appearance and pain and discomfort. CONCLUSIONS: 1) TX patients QOL isbetter than HD patients' in domains: overall, physical, social relationships and environment and alsoin facets: pain and discomfort, energy and fatigue, positive feelings, mobility, activities of dailyliving, working capacity, personal relationships, sexual activity and transport. 2) In the facet bodyimage and appearance, TX patients' QOL is worse than HD patients'. 3) The results point out the WHOQOL-100to be a useful and reliable instrument for measuring quality of life in different populations makingpossible to compare it objectively.
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






